fyi - paste from BTC's shareholder newsletter (25/02):
"Alchemia: There is no better example of investor dis-interest than ASX-listed company
Alchemia which is poised to begin generating significant income from the market launch of its
generic heparin product. Despite significant cash reserves (A$12 million) and near-term
revenue forecast by analysts in the order of A$30 million per annum investors value this
business at only A$20 million. In a normal market, Alchemia can reasonably be expected to
be re-rated significantly as income generation becomes a reality."
enough said.
BTC is a significant s'holder in ACL
- Forums
- ASX - By Stock
- TSN
- monkey buy at 11c
monkey buy at 11c, page-116
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable